Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-357-1 | CAS number: 16245-77-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labeling and/or risk assessment.
- Justification for type of information:
- This study was selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labeling and/or risk assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Remarks:
- The study was conducted according to guideline in effect at time of study conduct.
- Principles of method if other than guideline:
- Acute oral toxicity study of test chemical was performed in rodents.
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- p-phenylenediamine
- EC Number:
- 203-404-7
- EC Name:
- p-phenylenediamine
- Cas Number:
- 106-50-3
- Molecular formula:
- C6H8N2
- IUPAC Name:
- benzene-1,4-diamine
- Details on test material:
- - Name of test material:p-Phenylenediamine - Molecular formula :C6H8N2- Molecular weight :108.1432 g/mole - Substance type:Organic - Purity: 99.8%
Constituent 1
- Specific details on test material used for the study:
- - Name of test material :p-Phenylenediamine - Molecular formula :C6H8N2- Molecular weight :108.1432 g/mole - Substance type:Organic
Test animals
- Species:
- rat
- Strain:
- other: Sprague-Dawley Crl:OFA(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Age at study initiation: 6 or 7 weeks- Weight at study initiation: 132-186 g- Fasting period before study: Animals were fasted for at least 16 hours before dosing. Food was given 3 to 4 hours after dosing.- Housing: Animals were housed individually (during up and down procedure) or in groups of 4 or 5 (during acclimatisation period or main study) of the same sex in polycarbonate cages- Diet (e.g. ad libitum): ad libitum- Water (e.g. ad libitum): ad libitum- Acclimation period: at least 7 daysENVIRONMENTAL CONDITIONS- Temperature (°C): 22 ± 2 °C- Humidity (%): ≥ 40 %- Air Changes (per hr):minimum 15 air changes per hour- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: sterile water
- Details on oral exposure:
- no data available
- Doses:
- 100, 75, 50, 25 mg/kg bw
- No. of animals per sex per dose:
- 1, 2, 1, and 5 at 100, 75 , 50, and 25 mg/kg, respectively
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days - Frequency of observations: Morbidity/mortality checks and clinical observations were performed approximately 30 minutes, 1, 2, 4 and 6 hours after administration of the test substance, then twice daily during the observation period. Additional observations were performed in some animals on day 0. - Frequency of weighing: Individual body weights were recorded on day 0 before treatment, then on days 2, 7 and 14. - Necropsy of survivors performed: Yes; Animals found dead during the study were necropsied. All surviving animals were sacrificed and necropsied after the final observation (day 14).
- Statistics:
- No statistical analyses were performed. Body weight data were compared with historical control data concurrently available at the testing facility.
Results and discussion
- Preliminary study:
- The study was conducted according to an up and down procedure in order to determine the Maximum Tolerated Dose (MTD) then a main study was performed with 5 females. The starting dose level was 100 mg/kg, as chosen by the Study Sponsor. The first female initially received the test item at the starting dose level of 100 mg/kg and died 90 minutes after dosing. Based on the clinical observations of the first female (severe clinical signs and death), a second female received a lower dose level of 75 mg/kg. As no death occured, a third female received the same dose level (75 mg/kg) to confirm the toxicity observed. As mortality was noted at 75 mg/kg in 1/2 females, a fourth female was treated at the dose level of 50 mg/kg. As severe clinial signs were observed in the female treated at 50 mg/kg, an additional female was treated at the dose level of 25 mg/kg. No relevant clinical signs were observed, therefore the up and down procedure was considered ended and 4 additionnal females received the same dose level.
Effect levels
- Sex:
- female
- Dose descriptor:
- other: minimum lethal dose
- Effect level:
- 75 mg/kg bw
- Mortality:
- One animal died at 100 mg/kg within 90 minutes and one animal died at 75 mg/kg 2 hours and 45 minutes after treatment.
- Clinical signs:
- Treatment-related clinical signs, including marked subdued behaviour and unsteady gait, were observed in the female dosed at 100 mg/kg one hour after treatment. Orange traces in the bedding, probably due to coloured urine, were observed on day 0. The first female treated at 75 mg/kg had transitory treatment-related clinical signs (lachrymation and swelling of both conjunctiva), observed approximately 2 hours and 45 minutes to 6 hours after treatment. In addition subdued behaviour was noted 6 hours after treatment. No clinical signs were noted from day 1. Then a second female was treated at this dose level but died 2 hours and 45 minutes after treatment. Subdued behaviour, loss of balance, lateral decubitus and purplish paws were noted 2 hours after treatment up to death. Orange traces in the bedding, probably due to coloured urine, were observed on day 0 in both females. The female treated at 50 mg/kg had transitory treatment-related clinical signs, including lachrymation and swelling of both conjunctiva observed approximately 3 hours and 30 minutes after treatment and persisted up to 6 hours. In addition unsteady gait, tremors, subdued behaviour and/or piloerection were noted from approximately 5 hours up to 8 hours after treatment. No clinical signs were observed from day 1. Orange traces in the bedding, probably due to coloured urine, were observed on day 0. At 25 mg/kg, the only treatment-related observation was orange traces in the bedding, probably due to coloured urine, observed on day 0 in all females.
- Body weight:
- Though some individual body weights slightly exceeded the historical normal ranges, there was no effect of treatment on mean body weight or mean body weight gain in surviving animals during the study.
- Gross pathology:
- No macroscopic findings were seen in animals found dead during the study or at scheduled necropsy on day 14.
- Other findings:
- no data available
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The Minium lethal dose (MLD) value for acute oral toxicity test was considered to be 75 mg/kg bw,when female Sprague-Dawley Crl:OFA(SD) rats were treated with test chemical orally via gavage according to OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method).
- Executive summary:
Under the designated experimental conditions of the study, a single administration of the test substance by the oral route to female Sprague-Dawley rats induced deaths at 100 and 75 mg/kg and severe clinical signs at 50 mg/kg. No mortality and no clinical signs were noted at 25 mg/kg, whereas orange traces in the bedding were observed, probably related to orange-coloured urine. In conclusion, the minimal lethal dose of the test substance following single oral gavage to fasted rats was 75 mg/kg, the maximal non-lethal dose was 50 mg/kg and the no observed adverse effect level (NOAEL) was 25 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.